Early Diagnosis

Signs of cardiac amyloidosis are present earlier than many clinicians realize, and early diagnosis and treatment should save lives. Read Article ›

Cardiologists outline how to spot indicators of amyloidosis, what criteria to use to diagnose the disease, and how to distinguish between types of amyloidosis. Read Article ›

A new review outlines the applications and limitations of different options for the diagnosis of cardiac amyloidosis. Read Article ›

A guide to understanding the characteristics, diagnosis, and management of transthyretin amyloidosis is now available for multidisciplinary team members. Read Article ›

Cardiologists describe red flags that should raise suspicion of cardiac amyloidosis and provide a guide to noninvasive diagnostic techniques as alternatives to cardiac biopsy. Read Article ›

A guide describes how to use radiotracer scintigraphy for the accurate diagnosis of transthyretin amyloid cardiomyopathy. Read Article ›

Researchers from the United Kingdom analyzed the healthcare resources associated with diagnosis of transthyretin amyloidosis cardiomyopathy and estimated the time and cost-savings of an optimized diagnostic pathway. Read Article ›

The prevalence of transthyretin cardiac amyloidosis was nearly 28% in patients diagnosed with heart failure with preserved ejection fraction who have ≥2 red flags for cardiac amyloidosis. Read Article ›


Amyloidosis identified as the cause of heart failure in nearly 1 in 10 internal medicine patients. Read Article ›

Page 1 of 4

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.

I'd like to receive: